BNP Paribas’s Enzo Biochem, Inc. ENZ Stock Holding History

BNP Paribas’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-79	Closed	-$88	–	425
2024 Q3	$88	Buy	+79	New	+$88	﹤0.01%	374

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BNP Paribas's ENZ Position: Q4 2024 in Review

BNP Paribas sold out of Enzo Biochem, Inc. (ENZ) in Q4 2024, closing a stake of 79 shares — an estimated $88 sold.

BNP Paribas first reported a position in ENZ in Q3 2024 and held it in 1 quarter. The position peaked at $88 in Q3 2024. 45 funds tracked by Wall St. Rank hold ENZ as of Q4 2024.

BNP Paribas reported no remaining Enzo Biochem, Inc. position as of Q4 2024 after selling out during the quarter.
BNP Paribas sold 79 Enzo Biochem, Inc. shares in Q4 2024, an estimated $88.
BNP Paribas first reported a position in Enzo Biochem, Inc. in Q3 2024 and held it in 1 quarter.
BNP Paribas's Enzo Biochem, Inc. position peaked at $88 in Q3 2024.
45 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2024.

Based on BNP Paribas's 13F filing for Q4 2024, filed 14 Feb 2025.